Tag | Content |
---|
EnhancerAtlas ID | HS195-05808 |
Organism | Homo sapiens |
Tissue/cell | VCaP |
Coordinate | chr6:11228440-11230740 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
IRF1 | MA0050.2 | chr6:11230511-11230532 | TAGCTCTTTCTCTTTCTCTTA | + | 6.1 | NFAT5 | MA0606.1 | chr6:11229935-11229945 | AATGGAAAAT | - | 6.02 | NFATC1 | MA0624.1 | chr6:11229935-11229945 | AATGGAAAAT | - | 6.02 | NFATC3 | MA0625.1 | chr6:11229935-11229945 | AATGGAAAAT | - | 6.02 | Nr2f6(var.2) | MA0728.1 | chr6:11228547-11228562 | GAGGTCAAGAGTTCG | + | 6.24 | SP1 | MA0079.4 | chr6:11229622-11229637 | GGTGGGCGGGGCCTC | - | 6.53 | SP2 | MA0516.2 | chr6:11229621-11229638 | AGGTGGGCGGGGCCTCG | - | 6.06 | SP3 | MA0746.2 | chr6:11229622-11229635 | GGTGGGCGGGGCC | - | 6.14 | SP4 | MA0685.1 | chr6:11229620-11229637 | GAGGTGGGCGGGGCCTC | - | 6.65 |
|
| Number of super-enhancer constituents: 20 | ID | Coordinate | Tissue/cell |
SE_00114 | chr6:11206173-11235315 | Adipose_Nuclei | SE_01650 | chr6:11229205-11230387 | Aorta | SE_02337 | chr6:11229167-11234027 | Astrocytes | SE_20466 | chr6:11229912-11235018 | CD56 | SE_23016 | chr6:11230397-11235133 | CD8_primiary | SE_23435 | chr6:11229133-11234157 | Colon_Crypt_1 | SE_24670 | chr6:11229429-11229969 | Colon_Crypt_2 | SE_25994 | chr6:11228677-11234396 | Duodenum_Smooth_Muscle | SE_29527 | chr6:11228965-11234514 | Fetal_Intestine_Large | SE_29858 | chr6:11229433-11234718 | Fetal_Muscle | SE_32170 | chr6:11229317-11229951 | Gastric | SE_36359 | chr6:11229008-11235051 | HMEC | SE_37975 | chr6:11228930-11234114 | HUVEC | SE_41289 | chr6:11228669-11234466 | Left_Ventricle | SE_42296 | chr6:11227533-11228726 | Lung | SE_42296 | chr6:11229215-11234661 | Lung | SE_44826 | chr6:11229005-11233867 | NHLF | SE_45752 | chr6:11228816-11234113 | Osteoblasts | SE_52869 | chr6:11229171-11234762 | Small_Intestine | SE_65187 | chr6:11229056-11234743 | NHEK |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | GAGGTCATAA AAGCACGAAA GTGGGAGAGA ATTTGCAAAA AGGCCGGGTG CGGTGGCTCA 60 CACCTGTAAT CCCAGCACTT TGGGAGGCTG AGGCAGGTGG ATCACCTGAG GTCAAGAGTT 120 CGAGACCAGC CTGACCAACA CAGTGAAACC CATCTCTACT AAAAATACAA AACTTATCCA 180 GGCATGGTGG TGGGCACCTG TAATCCCAGC TACTCAGGAG GCCGAGACAG GAGAATCACT 240 TGAACCCAGG AGGCAGAGGT CGCAGTGAGC TGAGGTGGCA CCACTGCACT CCAGCCTGGG 300 CGACAGAGTG AGACTTGATC TCAAAAAAAG AAAAAAAGAA AAGTGGAGAG GAAGGTGTTT 360 TTTTCAGAAG ACTGGAGTGA AGGGAGAGAC AGGGAACCAC TGAATTCTGA GAACAGGGAC 420 TGACGTGTAT CCCAGCAAGG AAAGGATGCT AAAGGAATCC TTGGCATGTT ACGCACTGTA 480 CAACTTGCTA AATTTGGTAT TATCAGGCAC CTTCAGTACT CTAAAGGCTT TTATCTCTGT 540 GTAGGTAAGC CATTTAGCTC TGCAAATGGG TTTACTAAAT AAATAAATAA ATGCATAAAT 600 ACATAAATAA CCAAGTTGAT ATTTTTCAAA GCATGTTTTA GTGATTTTAA ATCCATAGAT 660 CTCATACAAG GTTTAAAAAG GAAAAGGACA GGAGTCCTAC ATTTGGATTG GTTGCAAAAA 720 TCATACAGAG AAAAATAAAG CATTTTAAAC CAAAATATCA AAGCAAGGAA ATAATTGGGA 780 ATTTAATAGC TTATGCATGA CCATATTGAC TAAATTAAAG ATCCTCTGTC ATTATTTTCC 840 TCGGTCTTGC TTGAGGAAAT ACGAATACTT TCAAAGTCCT TTCCAAAGCG TTTCACGGCA 900 CACAGGTTCT CCTTTCCCTG ACCTACCCCA TTCAACCAGA ACACAGGACT CTGACTTTCA 960 GAATGCACCT TTCTTAATGG CATTGTAAGT TCCGTCTGTA ATTTTTCTTC AGTCAAAACG 1020 TTAAAGAATG AATTTGTTGC ATGGTAGACG AGATAAATAA TTTAGAATTT TAATGTAGGC 1080 ACGTAAGGGC TCAGAAATTT GGCAAAGCCA CAAAAGCGTC TCTGCTCAGC CATTAGCAGC 1140 CAGGCCAAGG GGCCGCTGAG CCCCCGCCCG GGCTGGGCCT GAGGTGGGCG GGGCCTCGGG 1200 CCTGGCAGGC ACAAACGGGG TGGGGTCTCG GGGGCTTCTG CTCAAACACA GCTGCGCAGA 1260 GACCCTTCCA TCACCCTCCT GGGAAACAGC ACAACCATAC ACCTCCAGAC CCTCAGGAGG 1320 GAGCCTTCAC TGGGTAAGCA AACCAAGGCC ATCGAGGCAA TCACCTAACC CCGCCAGCCC 1380 CCGCCCAATT AAGAACATGC TCTGTATATG AAGGGGATTT TGTAGAAAAT TCTTAATAAA 1440 TGAAGCCCCC GTAATTTACT ATCACATAAC CACAGACTGA ATCCCTTCTA AGAGAAATGG 1500 AAAATTAAGT ACGTATGACA GTGACTGCAA CCTTCCTGTG GACAAATAAA AACATACAGG 1560 GAAATAAAGA CAGATTAGAT AAGTGCTAAC CAGAAATGTC TGTCCGGAGT AATAGCTTAC 1620 ATTCCACAGT TCTCAGGATT ACTGCAAGTA CCTTGCTGCC TGGCCTGAAG CTATGTATAT 1680 TAAGTGCAAA ATAAGTGAAG GTTTGTTGTT CCGTAGTTGT GATCCCTGGG GCAGCCAAAC 1740 CAGATAATCA GGTTAACAAC GACAATCTTA TAGGGCCTGA TTCATAAGTC TTTCAGTAAA 1800 CATTTTAAGG TTTGTGCTAA ATTTACAGTG CATAGAGCAA CGTAGTATTT TAGAGATAAT 1860 TCCTGTCTCT GGGATTTTAC CATCTAATAA TTATCTGGTT TTACTACCTA AGTGGCTCGA 1920 ATTAAACAAA TAACTGCCAA ACATGCACTT CATTTTGCTT TGTAGAGTTA CTATCTTAAA 1980 AAGAAATTAT CCTGCAGGAA TACTTGGGAT GAAATAGTCT TAAACTTTCT GGGAGAAGAA 2040 AACACTGGCC ATATTTTAGA GAGGTCAACG ATAGCTCTTT CTCTTTCTCT TAATAGTGGT 2100 TAAAGTCATG AGTTCTGGAG CCAGATCGCC TTAGTTCTAA TCCCAGCTCA CCACTTTCTA 2160 GCTGTGTGGC ATTAGATAAA TTACTTAGCC TCTCTGTGTC ATTTGAAATT GAGTATAAAA 2220 ATAATACCCA CCTTGTAGAG CTATTGGGAG AGTTGAATAT GACAATCTTG TGTTGTCACA 2280 GTAAGTCTCA ATTAATGTTA 2300
|